SUMMARY The effect of combined treatment with sulpiride plus cimetidine was compared against that of cimetidine alone on the healing of duodenal ulcer and on the subsequent relapse rate. In a double blind study, 35 patients with duodenal ulcer diagnosed by endoscopy were randomly assigned to receive cimetidine 800 mg daily and 38 patients to receive cimetidine 800 mg plus sulpiride 200 mg daily. Sixty patients whose ulcers were healed at three months continued to be observed after stopping treatment and underwent endoscopy to detect recurrences when symptomatic or at three and at six months if asymptomatic. Recurrence was observed in 18 (72%) of 25 patients whose ulcers had healed on cimetidine alone, but in only 11 (38%) of 29 patients whose ulcers healed on cimetidine plus sulpiride.
reported that cimetidine treatment results in an inadequacy of the mucosal defensive mechanism. Thus it would seem possible that the concomitant use of cimetidine and drugs that enhance mucosal defensive factors might prevent ulcer recurrence after withdrawal of treatment. Sulpiride, a nonsedative, hypothalamic neuroleptic, increases both mucosal blood flow in the gastroduodenal mucosa'l3 and mucus secretion. ' 4 This drug has not been shown to be a potent acid lowering agent, although it reduces meal related serum gastrin. ' Lam et al'" and Mihas and Mihas'7 reported a high ulcer healing rate with an antacid sulpiride combination, and suggested that sulpiride might be a helpful adjunct in ulcer treatment. In the present study, we therefore examined the effect of the combined use of sulpiride plus cimetidine on the recurrence of duodenal ulcer. subject, and the study was carried out in accordance with the Declaration of Helsinki. Endoscopic examinations were carried out less than seven days before starting treatment. All endoscopies were done by the same experienced endoscopist using a forward viewing fibreoptic panendoscope (Olympus GF-P3). The diameters of the ulcers were measured using the tip of the biopsy forceps. All patients were treated on an outpatient basis. By random allocation 35 patients were assigned to receive treatment with cimetidine only (200 mg three times daily after meals and at bedtime) and 38 patients to cimetidine plus sulpiride (200 mg of cimetidine and 50 mg of sulpiride three times daily after meals and at bedtime). All patients kept a daily record of their consumption of drugs, and attended the hospital once every two weeks. Endoscopy was carried out three months after starting treatment by the same endoscopist, who had no knowledge of the patient's treatment or clinical progress. Healing was defined as a bulb free of an ulcer crater. Patients whose ulcers were not healed at three months were withdrawn from the study. The remaining patients had no further medication, but attended the hospital once every four weeks to check for symptom recurrence. Endoscopy was carried out at the time of symptom recurrence, or at three and six months in those who remained asymptomatic, once again by the same endoscopist who remained unaware of the patient's earlier treatment. The reappearance of an 1512 ulcer crater was considered a recurrence whether symptoms were present or not, but the reappearance of erosions alone was not considered a recurrence.
After being accepted into the study, the patients were interviewed in detail with particular reference to the duration of their illness, cigarette and alcohol consumption, and ingestion of aspirin or nonsteroidal, non-salicylate, anti-inflammatory drugs (NSNSAID).
The smoking index was defined as the number of cigarettes smoked per day multiplied by the duration of smoking in years. In calculating the duration of smoking, any continuous pause in smoking lasting more than one year was subtracted. Individuals with a smoking index of over 400 were defined as 'heavy smokers'. Non-smokers were defined as never having smoked. No patients who smoked a pipe and/or cigars only or in addition to cigarettes were included in this study.
Consumption of alcohol, aspirin, and NSNSAID was defined as follows: '9 
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(1) Nil -less than 10 g/month; (2) Mild -10 g/month to less than 60 g/week; (3) Moderate -60 g/week to less than 60 g/day; (4) Heavy -60 g or more/day for at least one month. ASPIRIN Sixty patients with healed duodenal ulcer entered the follow up phase of the trial. Six patients were withdrawn, five (two healed on cimetidine and three on combination treatment) because they refused endoscopy and the sixth (healed on cimetidine) because there was no follow up information.
The results are sumlmarised in Table 1 . At six months, of 25 patients treated with cimetidine only, ulcers reappeared in 18 (72.0%). In contrast, ulcers recurred in only 11 of 29 (37-9%) patients who had been on combined cimetidine plus sulpiride (p<005). Symptomatic recurrence was more frequent in the former group (in 10 of 25 patients, 40%) than in the latter (five of 29, 17.2%) but not significantly so. The reappearance of duodenal erosions alone in the bulb was observed in five (20-0%) patients treated with only cimetidine but in none of those treated with cimetidine plus sulpiride. The differences of the incidence of heavy smokers with a smoking index of more than 4()) between the patients in whom ulcer did or did not recur was statistically significant (p<0-05 by using a combination of antacid and sulpiride. it would be theoretically possible to control the cephalic and gastric phases of acid secretion which occur with meals. Sulpiride, however, has not been shown to have a potent acid lowering effect. '5 Therefore, it seems likely that its effect on ulcer healing might be because of an improvement of mucosal defensive factors.
In the present study, we found that the combined use of cimetidine and sulpiride reduced recurrence of duodenal ulcers during the six month period after termination of cimetidine treatment, and therefore the protective effect of sulpiride exists even though the drug was given with cimetidine.
The causes of ulcer relapse have not been established. In the present work, we examined the influence of patient's variables on relapse rate. We found that heavy smoking was closely related to the ulcer recurrence, but no significant correlation between ulcer recurrence and other variables was found. These findings strongly indicate that physicians should encourage their patients to stop smoking, or failing this, reduce their daily cigarette consumption as much as possible.24 
